107 related articles for article (PubMed ID: 3614532)
1. [Results in oligodendroglioma: postoperative radiotherapy combined with chemotherapy].
Kitahara M; Katakura R; Mashiyama S; Niizuma H; Yoshimoto T; Suzuki J; Mori T; Wada T
No Shinkei Geka; 1987 Apr; 15(4):397-403. PubMed ID: 3614532
[TBL] [Abstract][Full Text] [Related]
2. [Long-term results of treatment in patients with oligodendrogliomas and oligoastrocytomas of the cerebral hemispheres].
Iun'pén V; Oliushin VE; Ulitin AIu; Maslova LN; Petrov AA
Zh Vopr Neirokhir Im N N Burdenko; 2008; (2):6-10; discussion 10-1. PubMed ID: 18720725
[TBL] [Abstract][Full Text] [Related]
3. [Results of combined radiochemotherapy of intracranial ependymoma].
Kitahara M; Katakura R; Kanno M; Niizuma H; Yoshimoto T; Suzuki J; Mori T; Wada T
No Shinkei Geka; 1987 May; 15(5):495-501. PubMed ID: 3114661
[TBL] [Abstract][Full Text] [Related]
4. Oligodendrogliomas.
Peterson K; Cairncross JG
Neurol Clin; 1995 Nov; 13(4):861-73. PubMed ID: 8584001
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
Abrey LE; Childs BH; Paleologos N; Kaminer L; Rosenfeld S; Salzman D; Finlay JL; Gardner S; Peterson K; Hu W; Swinnen L; Bayer R; Forsyth P; Stewart D; Smith AM; Macdonald DR; Weaver S; Ramsay DA; Nimer SD; DeAngelis LM; Cairncross JG
Neuro Oncol; 2006 Apr; 8(2):183-8. PubMed ID: 16524945
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and survival-related factors in patients with well-differentiated oligodendrogliomas.
Maiuri F; Del Basso De Caro ML; Iaconetta G; Peca C; Esposito M; de Divitiis E
Zentralbl Neurochir; 2006 Nov; 67(4):204-9. PubMed ID: 17106834
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):509-14. PubMed ID: 15145170
[TBL] [Abstract][Full Text] [Related]
8. Oligodendroglioma: clinical profile and treatment results.
Jacob R; Jyothirmayi R; Dalal Y; Nambiar U; Rajan B; Nair MK
Neurol India; 2002 Dec; 50(4):462-6. PubMed ID: 12577096
[TBL] [Abstract][Full Text] [Related]
9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
10. Treatment and prognosis of patients with intracranial nongerminomatous malignant germ cell tumors: a multiinstitutional retrospective analysis of 41 patients.
Ogawa K; Toita T; Nakamura K; Uno T; Onishi H; Itami J; Shikama N; Saeki N; Yoshii Y; Murayama S
Cancer; 2003 Jul; 98(2):369-76. PubMed ID: 12872359
[TBL] [Abstract][Full Text] [Related]
11. [Results of multimodal treatment of patients with glial tumors of cerebral hemispheres].
Cheremisin VM; Gaĭdar BV; Asaturian MA; Korobkova IM; Trufanov GE; Anosov NA
Vestn Rentgenol Radiol; 1995; (4):13-5. PubMed ID: 8571528
[TBL] [Abstract][Full Text] [Related]
12. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
13. Oligodendroglioma: does deferring treatment compromise outcome?
Feigenberg SJ; Amdur RJ; Morris CG; Mendenhall WM; Marcus RB; Friedman WA
Am J Clin Oncol; 2003 Jun; 26(3):e60-6. PubMed ID: 12796617
[TBL] [Abstract][Full Text] [Related]
14. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
15. Treatment of oligodendroglioma: an update.
Paleologos NA; Cairncross JG
Neuro Oncol; 1999 Jan; 1(1):61-8. PubMed ID: 11550303
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
17. [Association of 5-FU, CDDP and hypofractionated radiotherapy in recurrences of subtentorial astrocytomas and malignant gliomas in adults].
Bolla M; Vincent P; Benabid A; Mousseau M; de Rougemont J; Vrousos C; Kolodié H; Vincent F; Pasquier B
Bull Cancer Radiother; 1990; 77(1):53-9. PubMed ID: 8703542
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
19. Cerebral oligodendrogliomas in children: an analysis of 15 cases.
Rizk T; Mottolèse C; Bouffet E; Jouvet A; Guyotat J; Bret P; Lapras C
Childs Nerv Syst; 1996 Sep; 12(9):527-9. PubMed ID: 8906367
[TBL] [Abstract][Full Text] [Related]
20. Factors possibly influencing the prognosis of oligodendroglioma.
Sun ZM; Genka S; Shitara N; Akanuma A; Takakura K
Neurosurgery; 1988 May; 22(5):886-91. PubMed ID: 3380278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
